MapLight Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-78.8M | $-79.6M | $770.0K | $1.1M |
| FY2025 | $-138.1M | $-138.6M | $473.0K | $36.0M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-78.8M | $-79.6M | $770.0K | $1.1M |
| FY2025 | $-138.1M | $-138.6M | $473.0K | $36.0M |